Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Searches
(0)
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Online First
Supplements
NCCN Meeting Highlights
JNCCN In the News
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside
Search
Close
Advanced Search
Help
Volume 10 (2012): Issue 5 (May 2012)
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Get eTOC Alerts
Get Ahead of Print Alerts
Citation Alert
NCCN News
Pages: xv–xxi
Oncology Research Program
Pages: xxxiii–xxxiv
Continuing the Conversation: Questions on Cancer Care from the NCCN Annual Conference
By:
Staff
Pages: 567
Ten Years of Progress in Colon Cancer Therapy
By:
Paul F. Engstrom
Pages: 574–576
A Case of Diffuse Large B-Cell Lymphoma in Association With Paraesophageal Leiomyoma: Highlighting False-Positivity of PET Scan and Importance of Tissue Diagnosis
By:
Rajinder S. Grover
,
Kemp Kernstine
and
Amrita Krishnan
Pages: 577–581
Where is the EHR in Oncology?
By:
Jeremy Warner
and
Ephraim Hochberg
Pages: 584–588
Hodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines
By:
Richard T. Hoppe
,
Ranjana H. Advani
,
Weiyun Z. Ai
,
Richard F. Ambinder
,
Patricia Aoun
,
Celeste M. Bello
,
Philip J. Bierman
,
Kristie A. Blum
,
Robert Chen
,
Bouthaina Dabaja
,
Ysabel Duron
,
Andres Forero
,
Leo I. Gordon
,
Francisco J. Hernandez-Ilizaliturri
,
Ephraim P. Hochberg
,
David G. Maloney
,
David Mansur
,
Peter M. Mauch
,
Monika Metzger
,
Joseph O. Moore
,
David Morgan
,
Craig H. Moskowitz
,
Matthew Poppe
,
Barbara Pro
,
Jane N. Winter
,
Joachim Yahalom
and
Hema Sundar
Pages: 589–597
The Management of Patients With Stage IIIA Non–Small Cell Lung Cancer With N2 Mediastinal Node Involvement
By:
Renato G. Martins
,
Thomas A. D’Amico
,
Billy W. Loo Jr
,
Mary Pinder-Schenck
,
Hossein Borghaei
,
Jamie E. Chaft
,
Apar Kishor P. Ganti
,
Feng-Ming (Spring) Kong
,
Mark G. Kris
,
Inga T. Lennes
and
Douglas E. Wood
Pages: 599–613
Oral Chemotherapy Program Improves Adherence and Reduces Medication Wastage and Hospital Admissions
By:
Nikhil Khandelwal
,
Ian Duncan
,
Tamim Ahmed
,
Elan Rubinstein
and
Cheryl Pegus
Pages: 618–625
Cancer- and Chemotherapy-Induced Anemia
By:
George M. Rodgers III
,
Pamela Sue Becker
,
Morey Blinder
,
David Cella
,
Asher Chanan-Khan
,
Charles Cleeland
,
Peter F. Coccia
,
Benjamin Djulbegovic
,
Jeffrey A. Gilreath
,
Eric H. Kraut
,
Ursula A. Matulonis
,
Michael M. Millenson
,
Denise Reinke
,
Joseph Rosenthal
,
Rowena N. Schwartz
,
Gerald Soff
,
Richard S. Stein
,
Gordana Vlahovic
and
Alva B. Weir III
Pages: 628–653
Update on Safety of ESAs in Cancer-Induced Anemia
By:
John Glaspy
Pages: 659–666
Total Dose Iron Dextran Infusion in Cancer Patients: Is it SaFe
2+
?
By:
Jeffrey A. Gilreath
,
David D. Stenehjem
and
George M. Rodgers
Pages: 669–676
Measuring the Evidence That Informs Clinical Treatment Recommendations
By:
Jonathan L. Vandergrift
Pages: 678–680
Collapse
Expand
Search
Issue
Journal
[100.24.122.117]
100.24.122.117
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
